Amelito B Malapira
Neurology · Virginia Beach, VANPI 1710914239
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $184,843 of the $227,288 with a category attached, or 81.3%. 5 manufacturers reported payments, led by AbbVie at 57.6% of the total. Reporting peaked in 2019 at $75,123 and has fallen 93.8% since, to $4,686 in 2024. Among neurology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $789.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$131K
- Lilly USA, LLC$71K
- Biohaven Pharmaceuticals, Inc.$13K
- Biodelivery Sciences International, Inc.$8K
- Biohaven Pharmaceutical Holding Company Ltd.$4K
Across 91 payments — averaging $4768.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$390K
- Eli Lilly$43K
What the payments were for
- Consulting fees$18,9258%
- Speaking & faculty fees$184,84381%
- Grants$420%
- Travel & lodging$18,5648%
- Food & beverage$4,9002%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 120 | $130,857 |
| Lilly USA, LLC | 134 | $71,418 |
| Biohaven Pharmaceuticals, Inc. | 19 | $13,047 |
| Biodelivery Sciences International, Inc. | 11 | $7,572 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $4,394 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$67,986
- BOTOX$61,367
- EMGALITY$40,625
- NURTEC ODT$16,988
- REYVOW$13,888
- ELYXYB - CELECOXIB$7,259
How this compares
$227,288 in reported general payments places this provider in the 95th percentile of 474 neurology providers in Virginia.
Other neurology in Virginia Beach
- Michelle BetzVirginia Beach$250K
- Patrick KilhennyVirginia Beach$102K
- Ramsey FalconerAlexandria$2M
- Robert ShinCharlottesville$1.7M
- Heidi CraytonVienna$1.5M
- Mark LandrioWinchester$631K
- Catherine HamRichmond$603K
- Jill CramerChristiansburg$598K
- Rahul DaveFairfax$540K
- Daniel HardyRichmond$382K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.